Abbott’s $25 Rapid Virus Test Cleared for At-Home Use

Abbott Laboratories won U.S. authorization for a rapid Covid-19 test that costs $25 and can be used at home, a new accessible option from the manufacturer after months of obstacles to screening access in the country.

The emergency clearance from the Food and Drug Administration opens a new market for Abbott’s BinaxNOW, a single-use swab-collected test that produces results in 15 minutes. Until now, the test had been administered by health-care providers. Abbott is partnered with a service to remotely prescribe the screening.